Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.19p
   
  • Change Today:
      0.063p
  • 52 Week High: 8.00
  • 52 Week Low: 0.90
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 347,184
  • Market Cap: £2.88m
  • RiskGrade: 429
  • Beta: 0.04

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Erik Kristian Lium, Lorenzo Gallon, James Renwick McCullough

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 1.19p
Change Today 0.063p
% Change 5.56 %
52 Week High 8.00
52 Week Low 0.90
Volume 347,184
Shares Issued 242.54m
Market Cap £2.88m
Beta 0.04
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.52% above the market average34.52% above the market average34.52% above the market average34.52% above the market average34.52% above the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Price Trend
98.21% below the market average98.21% below the market average98.21% below the market average98.21% below the market average98.21% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
24.12% above the market average24.12% above the market average24.12% above the market average24.12% above the market average24.12% above the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average

Verici DX Dividends

No dividends found

Trades for 18-Jul-2025

Time Volume / Share Price
12:09 200,000 @ 1.00p
11:26 6,400 @ 1.00p
11:26 4,000 @ 1.25p
10:22 800 @ 1.25p
09:55 133,333 @ 0.90p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page